Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Manual of Nonpharmacological Control of Hypertension -

Manual of Nonpharmacological Control of Hypertension

J.R. Viskoper (Herausgeber)

Buch | Softcover
IX, 132 Seiten
1990
Springer Berlin (Verlag)
978-3-540-51070-3 (ISBN)
CHF 149,75 inkl. MwSt
The prevention and correction of high blood pressure obviously is not an end in itself but a means of preventing cardiovascular complications. It is tempting to res ort to antihypertensive drugs, for the simple reason that current preparations are easy to dose and to take. There is a variety of reasons, however, to take advantage of the antihypertensive potential of nonpharmaco logical approaches first. For one thing, the use of tablets tends to accentuate the negative effects oflabelling a subject as hypertensive. The act oftaking tablets per se may elicit a spectrum of subjective adverse effects, as we have learned from placebo-controlled therapeutic trials. Even more importantly, the benefits of antihypertensive drug treatment are largely confined to the reduction of stroke and disease of the large vessels. With regard to incidence of cardiac events, some modest beneficial effects have been registered, such as a decrease in congestive heart failure and in the fatality rate of myocardial infarction. The effects on the incidence of coronary heart disease are only marginal at best. This disappointing finding has been ascribed to various factors: unwanted metabolie effects of anti hypertensive drugs, inadvertent drops in diastolic pressure interfering with coro nary perfusion, and, last but not least, failure to eliminate risk factors other than high blood pressure (smoking, alcohol abuse, lipid and glucose disturbanees, obesity, and the hemodynamic disadvantages of a sedentary life). Most of these additional noxious factors are refractory to drug treatment and call for modifica tion of life-style.

Preface.- I: General Background.- 1 Risk Factors for Cardiovascular Disease and Their Control.- 2 The Role of the Family Practitioner in Hypertension Control.- 3 Patient Compliance with Health Behavior Programs.- 4 Communication Enhancement.- 5 Stress.- II: Implementation of Nonpharmacological Control of Hypertension and Other ASCVD Risk Factors.- 6 Nutritional Intervention.- 7 Physical Activity Enhancement.- 8 Stress Management.- 9 Cessation of Smoking.- 10 Promoting Compliance in Nonpharmacological Treatment.- III: The Israel Study of Nonpharmacological Control of Hypertension in Primary Care Practices.- 11 Program Design, Evaluation, Method, and Preliminary Results.- Accurate Measurement of Blood Pressure.- Forms for Chapters 6, 7, and 11.

Erscheint lt. Verlag 25.7.1990
Zusatzinfo IX, 132 p.
Verlagsort Berlin
Sprache englisch
Maße 170 x 242 mm
Gewicht 275 g
Themenwelt Geisteswissenschaften Psychologie Klinische Psychologie
Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
Medizinische Fachgebiete Innere Medizin Nephrologie
Medizin / Pharmazie Physiotherapie / Ergotherapie Rehabilitation
Schlagworte Blood pressure • Cardiovascular • Hypertension • non-pharmacologic control of CVO • Rehabilitation • risk factors • vascular disease
ISBN-10 3-540-51070-2 / 3540510702
ISBN-13 978-3-540-51070-3 / 9783540510703
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
in Fällen, Fragen und Antworten

von Christoph Spes; Volker Klauss; Sibylle Tönjes

Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 124,60
Diagnostik und interventionelle Therapie | 2 Bände

von Raimund Erbel; Michael Haude; Philipp Kahlert; Björn Plicht …

Buch (2024)
Deutscher Ärzteverlag
CHF 489,95